NR507 Discussion Week 1 response CM

/in /by

 

Wilbur presented to the office with symptoms of Kaposi Sarcoma and Oral candidiasis consistent with an untreated HIV/AIDS diagnosis. Kaposi sarcoma is caused by the human herpes virus 8 (HHV-8). It is typically contracted through saliva. While normal immune systems can combat the virus, immunocompromised patients such as those with HIV/AIDS are unable to suppress the virus, leading to red, purple, or brown lesions on the skin in addition to possible swelling of the legs and enlarged lymph nodes (Kaposi Sarcoma – Symptoms and Causes, n.d.). Oral candidiasis is a common opportunistic infection among patients with HIV/AIDS. Immuno-deficient patients are unable to properly regulate the amount of yeast growing in their body which may lead to oral pharyngeal symptoms such as white or yellow bumps or patches within the mouth, sore throat, difficulty swallowing, mouth sores, bleeding, and dry mouth (Yetman, 2021). 

In order to confirm the diagnosis for the conditions presented, if HIV is not confirmed, a HIV test should be ordered. In addition to an antibody/antigen test, a HIV-RNA viral load and CD4 test should be ordered as well. These conditions are more likely to manifest in patients with a CD4 count of less than 200, which is considered as AIDS defining. To confirm Kaposi sarcoma, a biopsy should be conducted on the lesions. Thrush can be diagnosed by examination. 

After a confirmed positive HIV diagnosis, the patient should be started on anti-retroviral therapy (ARV) immediately. With effective treatment, the patient can be virally suppressed and have an increase in their CD4 within 4-6 weeks. ARVs will enhance the patient’s immune system thus reducing the occurrence of opportunistic infections. Additional treatment should include surgical removal of kaposi sarcoma lesions, chemotherapy, or radiation. Treatment for thrush should include nystatin swish and swallow in addition to education about proper oral care. 

Kaposi sarcoma – Symptoms and causes. (n.d.). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/kaposis-sarcoma/symptoms-causes/syc-20577303Links to an external site.

Yetman, D. (2021, February 24). Oral thrush and HIV: what’s the connection? Healthline. https://www.healthline.com/health/hiv/oral-thrush-hivLinks to an external site.

NR507 Discussion Week 1 Response SB

/in /by

 

Application of Course Knowledge

Wilbur’s presentation aligns with Human Immunodeficiency Virus (HIV) based on his symptoms and clinical history. HIV is a virus that targets the immune system, particularly CD4+ T-helper cells, leading to immunosuppression. The progressive decline in immune function predisposes individuals to opportunistic infections and systemic complications.

One of the hallmark features of HIV is immune dysregulation, which leads to increased susceptibility to infections and inflammatory dermatological manifestations. Wilbur’s flat, purple-colored rash may be indicative of Kaposi’s sarcoma (KS), a common HIV-associated malignancy caused by human herpesvirus 8 (HHV-8). This condition is strongly associated with advanced HIV disease and AIDS. KS lesions often appear as non-painful, non-pruritic macules, plaques, or nodules, primarily on the skin but can involve mucosal surfaces and internal organs.

Another key finding is a white coating on the tongue, which suggests oral candidiasis (thrush)—a common opportunistic fungal infection in HIV patients due to Candida species overgrowth. Oral candidiasis frequently occurs in individuals with weakened immune function and is one of the early signs of HIV progression.

Additionally, Wilbur reports that he has “been sick a lot lately,” which may indicate recurrent infections, another hallmark of HIV due to its profound effect on immune function.

Diagnostic Tests

To confirm an HIV diagnosis in Wilbur, the following tests would be appropriate:

1.  HIV Screening Tests
   – HIV-1/2 antigen/antibody (4th-generation) test: Detects both HIV antibodies and the p24 antigen, providing an early diagnosis.
   – HIV RNA PCR (Nucleic Acid Amplification Test – NAAT): Useful for detecting acute HIV infection before seroconversion.

2.  CD4+ T-Cell Count and HIV Viral Load
   – CD4+ count: Measures immune system function; a count <200 cells/mm³ indicates AIDS.
   – HIV viral load (HIV RNA PCR): Assesses the level of virus in the blood and helps monitor disease progression.

3. Opportunistic Infection Testing
   – Biopsy of the skin rash: To confirm Kaposi’s sarcoma.
   – Potassium hydroxide (KOH) smear or fungal culture for oral candidiasis.
   – Complete Blood Count (CBC) and Comprehensive Metabolic Panel (CMP) to assess overall health status and detect abnormalities associated with HIV.

Comparison with Other Conditions

A peer analyzing Wilbur’s case through the lens of Systemic Lupus Erythematosus (SLE) might focus on the rash and recurrent infections, as SLE can also present with skin lesions and immune dysfunction. However, Wilbur’s purple-colored rash is more suggestive of Kaposi’s sarcoma rather than the malar (butterfly) rash seen in SLE. Furthermore, SLE-related rashes are often photosensitive, which is not mentioned in Wilbur’s case.

Additionally, oral candidiasis is not a common feature of SLE but is strongly associated with immunosuppression, as seen in HIV. While both conditions can lead to increased susceptibility to infections, the presence of an AIDS-defining illness like Kaposi’s sarcoma strongly supports an HIV diagnosis over SLE.

Conclusion

Wilbur’s symptoms, including the purple-colored rash, oral candidiasis, and frequent illnesses, align closely with the pathophysiology of HIV/AIDS rather than SLE or allergies. Diagnostic testing, including HIV screening, CD4 count, viral load, and opportunistic infection screening, would be the next appropriate step. If confirmed, timely antiretroviral therapy (ART) is essential for managing his condition and preventing further complications.

References
Fauci, A. S., Lane, H. C. (2020). Human Immunodeficiency Virus Disease: AIDS and Related Disorders. Harrison’s Principles of Internal Medicine, 21st Edition.
Panel on Antiretroviral Guidelines for Adults and Adolescents. (2023). Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services.
Centers for Disease Control and Prevention (CDC). (2023). HIV Basics. Retrieved from [https://www.cdc.gov/hiv/basics/](https://www.cdc.gov/hiv/basics/)

Pathophysiology Adventure Part 1 of 3 New

/in /by

 My disease will be:  HIV and Mental Health

Include the following sections: 

Application of Course Knowledge: Answer all questions/criteria with explanations and detail.  

  1. Select a condition covered in this course that interests you or is relevant to your nursing practice. Identify the condition you’ve selected. 
  2. Briefly explain your rationale for selecting this particular condition. What influenced your selection? 
  3. Investigate the prevalence and incidence of the chosen condition in the United States (U.S.). What are the incidence, prevalence, and affected populations? 
  4. Find and summarize a scholarly article that discusses your selected condition. What does the article say about your condition and its pathophysiology and manifestations? How is the article relevant to your understanding of the condition? 

Neuroscience for psychiatrist mental health practitioners.

/in /by

 

Neuroscience has revolutionized our understanding of the brain and its role in mental health. From neuroimaging to neuroplasticity, the field has made tremendous strides in recent years. As future psychiatric nurse practitioners, it’s essential to explore the benefits of integrating neuroscience into clinical practice.

Consider the following questions:

– How has neuroscience informed our understanding of psychiatric disorders, such as depression, anxiety, and schizophrenia?

– How can we use neuroscientific findings to improve patient outcomes, such as personalized treatment plans or novel pharmacological approaches?

Share your thoughts, insights, and experiences on the benefits and potential breakthroughs of neuroscience in clinical psychiatry.

due 14 hours

/in /by

assignment attach below.

focused noted-6531

/in /by

Create a reply for a Discussion using APA 7 format, and scholarly references no older than 5 years.

/in /by

Please ensure that the reply includes more than 200 words with scholarly articles, and the plagiarism level must remain below 20%.

The Theory of Unpleasant Symptoms (TOUS) emphasizes that symptoms are multifaceted, influenced by physiological, psychological, and situational factors (Fink et al. 20202). To align with this framework, an effective symptom assessment tool should capture not only the severity and frequency of symptoms but also their broader impact on a patient’s quality of life, emotional well-being, and functional ability. Recent studies have reinforced the need for comprehensive tools that assess the full range of symptoms, taking into account the interaction between physical and psychological distress.

For instance, Fink et al. (2020) highlighted the importance of tools that assess symptom burden in chronic illnesses, emphasizing that symptom severity alone does not reflect the total impact on a patient’s life. The Edmonton Symptom Assessment System (ESAS) is an example of a tool that measures not only the intensity of symptoms like pain and fatigue but also their interference with daily activities and emotional well-being. This aligns with the TOUS framework by considering how symptoms affect a patient’s overall functioning, not just their physiological state.

Psychological factors are also integral to the symptom experience. Jafari et al. (2022) found that emotional responses such as anxiety and depression significantly affect how symptoms are perceived, with these psychological states often exacerbating physical symptoms. Tools that assess emotional distress, such as the Hospital Anxiety and Depression Scale (HADS), are crucial in providing a complete picture of symptom experience. By addressing both the physical and psychological components, clinicians can gain a better understanding of the complexity of symptoms and tailor interventions accordingly.

Cultural sensitivity is another essential aspect of symptom assessment. Smith et al. (2021) stressed the importance of using culturally appropriate tools to capture symptom experiences in diverse populations. This ensures that symptom assessments are accurate and respectful of cultural differences, which can influence symptom expression and interpretation. In this way, symptom assessment tools can be more inclusive and reflective of the patient’s unique context.

In summary, a well-rounded symptom assessment tool, based on the Theory of Unpleasant Symptoms, should encompass physical, psychological, and contextual elements. By using tools like the ESAS and HADS, healthcare providers can better understand and address the full scope of the patient’s symptom experience, leading to more effective and personalized care.

References:
Fink, P., Hansen, M. S., & Benros, M. E. (2020). The burden of somatic symptoms in chronic illness: A clinical perspective. Psychosomatic Medicine, 82(2), 110-118. https://doi.org/10.1097/PSY.0000000000000782

Jafari, H., Asgarian, A., & Marzbani, H. (2022). The role of emotional distress in symptom perception in chronic illness: A systematic review. Journal of Clinical Psychology, 78(4), 812-823. https://doi.org/10.1002/jclp.23293

Smith, A., Li, Y., & Zhang, Q. (2021). Cultural considerations in symptom assessment: A global perspective. International Journal of Nursing Studies, 58(3), 54-64. https://doi.org/10.1016/j.ijnurstu.2021.03.005

Create a reply for a Discussion using APA 7 format, and scholarly references no older than 5 years.

/in /by

Please ensure that the reply includes more than 200 words of scholarly articles and that the plagiarism level remains below 20%.

Based on the multi-dimensional nature of patient symptoms, the Theory of Unpleasant Symptoms (TOUS) offers a comprehensive framework of strategies to evaluate patient symptoms. This is the interplay between symptoms, their effects on performance, and other consequences of failing due to those symptoms. In selecting patient symptoms for assessment based on TOUS, it is important to prioritize several key items to obtain an accurate and comprehensive evaluation of patients.

One of the most important things about TOUS is that symptoms are not one-dimensional but multi-dimensional, referring to intensity, duration, frequency, and distress. Any good assessment tool should be something other than just a tool to ascertain or quantify the presence and/or severity of a symptom. Instead, it should assess how such symptoms change over time and what impact they have on the total welfare of the patient. For instance, in patients suffering from chronic illnesses, including fatigue, cognitive impairment, emotional distress, and pain, an effective tool should capture not just pain levels but also all the occurring co-morbid symptoms (Srivastava & RM, 2021).

TOUS states that the symptoms are determined by physiological and psychological factors, as well as situational ones and considered factors that affect the severity and perceived symptoms. Physiological factors include the disease pathology, the medication side effects, or a genetic predisposing factor. Elements of a psychological nature, such as anxiety or depression, can accentuate the intensity of symptoms, which is even more distressing for the patient. Additionally, environmental and situational factors—such as access to healthcare, socioeconomic status, and social support—play a crucial role in symptom management (Moore, 2022). The assessment tool would be a complete picture of the patient’s condition only if questions incorporate these influencing factors.

An ideal assessment tool must assess, in addition to the symptoms, how the symptoms affect daily life. TOUS stresses that the symptoms have an impact on the physical, cognitive, and social functions. For instance, in an effort to assess cancer-related fatigue, tiredness should be quantified but also looked at in terms of its impact on mobility, work performance, and social interactions. Healthcare providers can tailor interventions to improve quality of life rather than just treating the symptoms of the individual by assessing how he is functioning as a whole (Moore, 2022).

The assessment tool should also be validated for reliability and sensitivity in many patient populations. If a timely clinical intervention can be made based on subtle changes over time in symptoms, then this tool should be useful. When the tool is evidence-based, point-scored, and rigorously tested, it provides a good application to practice.

Finally, an ideal assessment approach, under the heading of TOUS, should be comprehensive enough to assess symptom dimensions, influence factors, and functional outcomes, and it has to be reliable. Treatment strategies and outcomes are better when the effects of symptoms are approached holistically.

References

Moore, A. K. (2022). The holistic theory of unpleasant symptoms. Journal of Holistic Nursing, 40(2), 193-202. https://journals.sagepub.com/doi/full/10.1177/08980101211031706

Srivastava, S. P., & RM, N. T. (2021). Insight into the theory of unpleasant symptoms. International Organization of Scientific Research Journal of Nursing and Health Science, 10(3), 23-26. https://www.researchgate.net/nsight_into_the_theory_of_unpleasant_symptoms/links/60a0a25192851cfdf3381647/Insight-into-the-theory-of-unpleasant-symptoms.pdf

discussion post

/in /by

Is your clinical change project highly significant to nursing? Does the project encompass the core graduate nursing competencies of patient-centered care, social equity, cultural appropriateness, evidence-based practice, health promotion, and disease prevention? Why?

Patient Medication Guide

/in /by

Creating a visually appealing medication guide